Latest Psychiatry and Mental Health research
The 10 most useful psychiatry and mental health studies published this week, chosen from Q1 journals and graded on the Oxford CEBM evidence hierarchy. Each paper links to a short summary and the original on PubMed. Updated 22 September 2026.
Top 10 this week
Week of 20 September 2026
- 1
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind Trial
The Journal of clinical psychiatry · Q1 journal · RCT · Evidence level 1 (High) · 14 September 2026
Adjunctive lumateperone improves depression and anxiety scores
- 2
Virtual Reality-Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial
JMIR mental health · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026
VR‑assisted therapy vs CBT for treatment‑resistant schizophrenia
- 3
Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction
General psychiatry · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026
Open‑label randomised trial of agomelatine augmentation for negative symptoms
- 4
Five-year outcomes in a randomised controlled trial of prolonged exposure therapy and supportive counselling for post-traumatic stress disorder in adolescents: a task-shifted intervention
European journal of psychotraumatology · Q1 journal · RCT · Evidence level 1 (High) · 14 September 2026
In a randomized trial of 63 adolescents, both brief prolonged exposure therapy and supportive counseling delivered by non-specialist nurses reduced PTSD symptoms for up to 60 months, but exposure produced greater symptom drops at every follow-up except the final five-year point. The durability of these improvements supports scaling task-shifted trauma therapies in community settings, though the long-term advantage of exposure over counseling appears modest.
- 5
Cost-Effectiveness of Community-Based Rehabilitation for People With Schizophrenia: A Secondary Analysis of a Cluster Randomized Trial
JAMA health forum · Q1 journal · RCT · Evidence level 1 (High) · 4 September 2026
Adding a year-long group-based community rehabilitation program to standard psychiatric care improved symptoms, social functioning, and caregiver burden while cutting costs, yielding savings of about $25,000 per QALY gained. The analysis showed a >90% chance of cost-effectiveness, suggesting the model could be scaled in low-resource settings, though long-term outcomes remain to be studied.
- 6
Adjunctive GLP-1 receptor agonists for cardiometabolic risk in antipsychotic-treated patients: A GRADE-assessed meta-analysis of randomized trials
Journal of psychopharmacology (Oxford, England) · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 16 September 2026
GLP‑1 RA improves weight, BMI, glucose in antipsychotic patients
- 7
A smartphone-based serious game to improve mental health and medication adherence in adults with depression: A randomised controlled trial
Journal of affective disorders · Q1 journal · RCT · Evidence level 1 (High) · 18 September 2026
In 148 adults on antidepressants, a 9-week smartphone serious game plus optional CBT modules and on-demand therapist support cut depressive scores more than a waitlist, with 51% reaching at least a 30% improvement versus 19% controls; anxiety and medication adherence improved modestly. Higher dropout in the game arm and the open-label design temper confidence in the findings.
- 8
Systematic Review and Meta-Analysis: Lack of Early Improvement Predicts Inefficacy of Antipsychotics for Schizophrenia in Adolescents
Journal of the American Academy of Child and Adolescent Psychiatry · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 15 September 2026
Systematic review of early improvement predicting antipsychotic efficacy in adolescents
- 9
Integrated Mental Health Care for Perinatal Anxiety and Depression in the United States: A Systematic Review
Psychiatric services (Washington, D.C.) · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 17 September 2026
Systematic review of integrated perinatal mental‑health care
- 10
Modularised CBT for children with anxiety disorders: client feedback and therapeutic alliance as predictors of treatment outcome
Behavioural and cognitive psychotherapy · Q1 journal · RCT · Evidence level 1 (High) · 14 September 2026
Recent Psychiatry and Mental Health research from a high-quartile journal
Paper of the day, last two weeks
Comparing lithium and valproate in reducing suicide risk: A territory-wide retrospective cohort study with pairwise and network meta-analysis
Psychological medicine · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 21 September 2026
Lithium vs valproate suicide risk meta‑analysis
Targeting the dopaminergic midbrain with precision 7-Tesla biofeedback training in depression: A proof-of-principle randomized controlled trial
Molecular psychiatry · Q1 journal · RCT · Evidence level 1 (High) · 19 September 2026
In a randomized trial of 62 unmedicated adults, active 7-Tesla fMRI neurofeedback targeting the dopaminergic midbrain produced a measurable improvement in depressed mood and negative affect immediately after training and still at 24 hours, but the benefit faded by one week. The intervention also strengthened ventral tegmental area-frontal connectivity, suggesting a mechanistic link, yet larger studies are needed to confirm durability.
Effects of different types of mind-body exercises on depressive symptoms in older adults: a systematic review and network meta-analysis
Frontiers in public health · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 31 August 2026
Mind‑body exercises for depressive symptoms in older adults
Effectiveness and moderators of PE and CPT in adult PTSD treatment: a systematic review and meta-analysis
European journal of psychotraumatology · Q1 journal · SR of cohorts · Evidence level 2 (Moderate) · 9 September 2026
Meta‑analysis of PE vs CPT for adult PTSD
Which exercise strategies improve postpartum depression? A systematic review and meta-analysis of randomized controlled trials
Frontiers in public health · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 27 August 2026
Which exercise strategies improve postpartum depression? Systematic review and meta‑analysis
Effectiveness of the hope groups intervention on mental health, parenting practices, and violence against children among Ukrainian parents and caregivers affected by war and displacement: a cluster randomised controlled trial
The Lancet regional health. Europe · Q1 journal · RCT · Evidence level 1 (High) · 25 August 2026
In a cluster randomised trial of 510 Ukrainian caregivers displaced by war, the 12-session Hope Groups program reduced caregiver depression and anxiety by more than half and lowered reported violence against children by about half, while improving parenting practices. The intervention was well-accepted with no harms, suggesting a scalable approach for families in conflict zones, though longer-term effects remain to be studied.
Mapping 20-Year Global Functioning Trajectories in Schizophrenia Spectrum Disorders
Schizophrenia bulletin · Q1 journal · RCT · Evidence level 1 (High) · 20 August 2026
In a 20-year follow-up of 376 first-episode patients, three trajectories emerged: 21% maintained high functioning, 37% improved then declined, and 42% remained disabled. Male sex, older age, schizophrenia diagnosis, severe negative symptoms and lack of high-school education predicted the impaired trajectory, which was linked to worse symptoms, cognition, quality of life and higher suicide risk.
The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial
The lancet. Psychiatry · Q1 journal · RCT · Evidence level 1 (High) · 1 October 2026
In a 130-patient trial, adding a manualised psychodynamic program to usual care improved psychosocial functioning by about 3.5 points at two years and 4 points at three years on the Mini-ICF-APP scale, with similar safety to standard care. The result suggests a durable benefit, but replication in larger, multi-center studies is needed.
Effect of dopamine partial agonist antipsychotics on suicide risk in persons with schizophrenia and schizoaffective disorders: A systematic review and meta-analysis
Schizophrenia research · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 8 September 2026
A systematic review and meta-analysis of randomized trials found that dopamine partial agonists did not significantly change suicide deaths, attempts, or ideation compared with placebo (risk ratio around 0.65, not statistically significant). Open-label extension studies showed a modest increase in suicidal outcomes but were highly heterogeneous, so no firm conclusions can be drawn. Further trials are needed to identify a clozapine-alternative for suicide prevention.
Evidence summaries in Psychiatry and Mental Health
Get this list every morning
The Web of Medicine app builds this feed for your specialty daily, with filters by evidence level and journal, audio summaries and Ask AI. Free on iOS and Android.
For healthcare professionals. Summaries are generated by AI from the published abstract and are not medical advice. Read the original paper before changing practice.